quidel corp. Resources | BNET
On CNET: Featured Freeware - PhotoScape

BNET Industries

Quidel Corp. (QDEL) is in the Pharma Industry

Revenue
Dec 31 2007
$118.0M
Profit
Dec 31 2007
$13.6M
Market Cap
Sep 04 2008
$594.5M

Latest News and Analysis

Additional Resources

  • Quidel Reports Second Quarter 2008 Results

    Year-to-Date Net Income Increased 159% on a 20% Increase in Revenues SAN DIEGO -- Conference call information, first U.S. dial-in number should read: 1-800-561-2601 (sted (888) 561-2601). The corrected release reads: QUIDEL REPORTS SECOND QUARTER 2008 RESULTS Year-to-Date Net Income Increased 159%...

    Articles 2008-07-23

  • Quidel to Hold 2008 Second Quarter Conference Call on July 23, 2008

    SAN DIEGO -- Quidel Corporation (NASDAQ:QDEL), a leading provider of rapid point-of-care POC diagnostic tests, will release 2008 second quarter financial results after market close on Wednesday, July 23, 2008. Following the release of the results, Caren L. Mason, president and chief executive officer, and...

    Articles 2008-07-09

  • Examine the World Peptic Ulcer Testing Market

    Reportlinker.com announces that a new market research report related to the Laboratory equipment industry is available in its catalogue. World Peptic Ulcer Testing Market http://www.reportlinker.com/p090666/World-Peptic-Ulcer-Testing-Market.html This report analyzes the worldwide markets for Peptic Ulcers Testing in Millions of US$. The report provides separate comprehensive...

    Articles 2008-07-07

  • Mergent, Inc. Announces Quarterly Rebalancing of HealthShares™ Indexes

    NEW YORK, June 17 /PRNewswire/ -- Mergent, Inc., administrator for the HealthSharesTM Indexes, a series of 20 underlying indexes for the HealthSharesTM Exchange Traded Funds, today announced the quarterly rebalancing of the Indexes. The following securities will be added and deleted in the Indexes effective before...

    Articles 2008-06-17

  • EraGen Announces Appointment of Vader as Vice President, Quality, Regulatory and Clinical Affairs

    MADISON, Wis. -- EraGen Biosciences Inc. today announced the appointment of Randal Vader as vice president, quality, regulatory and clinical affairs. Mr. Vader brings more than two decades of quality systems, and regulatory and clinical affairs leadership to his new role at EraGen. His experience...

    Articles 2008-06-12

  • Quidel and Prodesse Announce Flu and RSV Molecular Partnership

    SAN DIEGO -- Quidel Corporation (NASDAQ:QDEL), a leading provider of rapid point-of-care POC diagnostic tests, and Prodesse, Inc., a biotechnology company focused on developing molecular diagnostic reagents for a variety of infectious diseases, announced today an agreement between the two companies to jointly promote Prodesse's ProFlu+[TM] multiplex molecular diagnostic test...

    Articles 2008-05-20

  • Rapid aid in diagnosis

    The QuickVue Respratory syncytial virus RSV test has been granted CLIA-waived status. This dipstick immunoassay allows for the rapid, qualitative detection of RSV antigen directly from nasopharyngeal swab or nasopharyngeal aspirate specimens for symptomatic pediatric patients (18 and younger). [ILLUSTRATION OMITTED] Quidel ...

    Articles 2008-05-01

  • Quidel Reports First Quarter 2008 Results

    Earnings Per Share Increased 86 Percent to $0.26 on a 20 Percent Increase in Revenues SAN DIEGO -- Quidel Corporation (NASDAQ: QDEL), a leader in point-of-care rapid diagnostic tests, today announced financial results for the three months ended March 31, 2008. Recent Highlights: *...

    Articles 2008-04-23

  • Quidel to Hold 2008 First Quarter Conference Call on April 23, 2008

    SAN DIEGO -- Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid point-of-care POC diagnostic tests, will release 2008 first quarter financial results after market close on Wednesday, April 23, 2008. Following the release of the results, Caren L. Mason, president and chief executive officer, and John M....

    Articles 2008-04-09

  • Quidel Corporation and Susie's Cause Partner in Colorectal Cancer Awareness Event

    SAN DIEGO -- Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid point-of-care diagnostic tests, announced today that it is participating at an educational program and special event at "Gunther von Hagens' Body Worlds 2 & The Brain - Our Three Pound Gem" exhibit at the Maryland Science Center in...

    Articles 2008-03-04

  • FDA Grants CLIA Waiver for Quidel's QuickVue® RSV Test

    SAN DIEGO -- Quidel Corporation (NASDAQ:QDEL), a leading provider of rapid point-of-care POC diagnostic tests, announced today that the U.S. Food and Drug Administration FDA granted CLIA waiver for the QuickVue([R]) RSV test for the qualitative detection of respiratory syncytial virus RSV. The waiver makes the QuickVue RSV test more...

    Articles 2008-02-29

  • Urgent news alert: Arthritic Pain Relief, Diabetes Awareness, Point of Care Diagnostic Test FDA Approval of CLIA Waiver & Pharmaceutical Conference Dates Stock News for You.

    M2 PRESSWIRE-29 February 2008-Businessnetwire.us: Urgent news alert: Arthritic Pain Relief, Diabetes Awareness, Point of Care Diagnostic Test FDA Approval of CLIA Waiver & Pharmaceutical Conference Dates Stock News for YouC1994-2008 M2 COMMUNICATIONS LTD RDATE:29022008 New York, NY -- HealthSonix,...

    Articles 2008-02-29

  • Quidel Reports Fourth Quarter and Full Year 2007 Results

    For the Year, Operating Income Increased 41 Percent on an 11 Percent Increase in Revenues SAN DIEGO -- Quidel Corporation (NASDAQ: QDEL), a leader in point-of-care rapid diagnostic tests, today announced financial results for the three months and year ended December 31, 2007. Full Year 2007...

    Articles 2008-02-21

  • BellwetherReport.com Analyst Review for QDEL, BPHX, SHOO and KALU

    BellwetherReport.com is the leading onlinefinancial newsletter for investors seeking top independent and unbiasedresearch on NYSE, NASDAQ, AMEX, TSX, TSX-Venture and US Small-Cap listedcompanies. Investors seeking unbiased research on the companies mentionedare highly encouraged to sign up to www.bellwetherreport.com for a free 90day subscription. Today we have set up...

    Articles 2008-02-19

  • Quidel to Hold 2007 Fourth Quarter and Year-End Financial Results Conference Call on February 21, 2008

    SAN DIEGO -- Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid point-of-care POC diagnostic tests, will release 2007 fourth quarter and year-end financial results after market close on Thursday, February 21, 2008. Following the release of the results, Caren L. Mason, president and chief executive officer, and...

    Articles 2008-02-11

  • Quidel and bioMerieux Announce a Global Strategic Alliance in Rapid Diagnostics

    SAN DIEGO & MARCY L'ETOILE, France -- Quidel Corporation (NASDAQ: QDEL) and bioMerieux (Euronext: BIM) have agreed to form a long-term global alliance in the area of rapid clinical diagnostics for the point-of-care. bioMerieux will become Quidel's primary distributor for its QuickVue([R]) rapid diagnostic tests outside the United States and...

    Articles 2008-01-15

  • Quidel Corporation and Roche to Collaborate in Pilot Program for Influenza Management in U.S. This Flu Season

    Tamiflu([R]) and QuickVue([R]) to Be Utilized Jointly to Facilitate Timely Diagnosis, Treatment and Prevention of Flu SAN DIEGO -- Quidel Corporation (NASDAQ:QDEL), a leading provider of rapid point-of-care POC diagnostic tests, announced today the launch of a pilot program with Roche in the U.S. this...

    Articles 2007-12-06

  • page 1 of 1
  • Incorporated: 1979
  • CEO: Ms. Caren L. Mason

Quidel is engaged in the development, manufacture and marketing of point-of-care rapid diagnostics for detection and management of a variety of medical conditions and illnesses. The majority of Co.'s products are developed for the physician office lab and acute care market and are focused on infectious diseases and reproductive and women's health. Co.'s products are sold to professionals for use in physician offices, hospitals, clinical laboratories, retail clinics and wellness screening centers through a network of national and regional distributors, supported by a national sales force.

Key Competitors

advertisement
Quidel Corp. Company Info

Board of Directors

Mr. Mark A. Pulido

Chairman

Ms. Caren L. Mason

Mr. Thomas D. Brown

Dr. Kenneth F. Buechler Ph.D.

Mr. Rod F. Dammeyer

Dr. Mary Lake Polan Ph.D.

Mr. Jack W. Schuler

Contact Information

10165 McKellar Court

San Diego, CA

http://www.quidel.com

858 552-1100

NAICS Code

In-Vitro Diagnostic Substance Manufacturing: 325413
advertisement